DE69017915D1 - Zubereitung für den magen. - Google Patents

Zubereitung für den magen.

Info

Publication number
DE69017915D1
DE69017915D1 DE69017915T DE69017915T DE69017915D1 DE 69017915 D1 DE69017915 D1 DE 69017915D1 DE 69017915 T DE69017915 T DE 69017915T DE 69017915 T DE69017915 T DE 69017915T DE 69017915 D1 DE69017915 D1 DE 69017915D1
Authority
DE
Germany
Prior art keywords
desirably
release portion
stomach
preparation
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69017915T
Other languages
English (en)
Other versions
DE69017915T2 (de
Inventor
Kouichi Ushimaru
Kouichi Nakamichi
Hiroyuki Yasuura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of DE69017915D1 publication Critical patent/DE69017915D1/de
Publication of DE69017915T2 publication Critical patent/DE69017915T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69017915T 1989-10-26 1990-10-24 Zubereitung für den magen. Expired - Fee Related DE69017915T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27929389 1989-10-26
PCT/JP1990/001365 WO1991006281A1 (en) 1989-10-26 1990-10-24 Gastric preparation

Publications (2)

Publication Number Publication Date
DE69017915D1 true DE69017915D1 (de) 1995-04-20
DE69017915T2 DE69017915T2 (de) 1995-07-27

Family

ID=17609152

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69017915T Expired - Fee Related DE69017915T2 (de) 1989-10-26 1990-10-24 Zubereitung für den magen.

Country Status (5)

Country Link
US (1) US5368861A (de)
EP (1) EP0497977B1 (de)
AT (1) ATE119766T1 (de)
DE (1) DE69017915T2 (de)
WO (1) WO1991006281A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
KR100347631B1 (ko) * 1993-12-10 2002-11-29 후지사와 야꾸힝 고교 가부시키가이샤 해열진통배합제
WO1996012477A1 (en) * 1994-10-21 1996-05-02 Leiras Oy Controlled release oral delivery system containing oxybutynin
US5807579A (en) * 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
WO1997047285A1 (en) * 1996-06-10 1997-12-18 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
ES2129356B1 (es) * 1997-03-26 2000-01-16 Pierre Fabre Iberica S A Forma farmaceutica de liberacion prolongada y procedimiento para su o btencion.
US6171615B1 (en) 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
US6492488B1 (en) * 1998-08-02 2002-12-10 Pmd Holdings Corp. Controlled release polyacrylic acid granules and a process for preparing the same
CA2313504C (en) 1999-07-12 2007-05-29 Douglas P. Debernardi Folic acid in solid dosage forms
AU5060499A (en) * 1999-08-04 2001-03-05 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
US6248359B1 (en) 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US7985420B2 (en) 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US8012504B2 (en) 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
HUP0402611A2 (hu) * 2001-10-08 2005-07-28 Sun Pharmaceutical Industries Limited Görcsoldó hatóanyag szakaszos leadására szolgáló rendszer
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040229849A1 (en) * 2002-09-24 2004-11-18 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
ITMI20022343A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Pellicola a rapida dissoluzione in acqua, contenente sistanze cosmetiche, aromatiche, farmaceutiche o alimentari.
DE102005011029A1 (de) * 2005-03-08 2006-09-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die perorale Applikation mit gesteuerter Freisetzung von Wirkstoffen
JPWO2007069358A1 (ja) * 2005-12-14 2009-05-21 キッセイ薬品工業株式会社 新規胃内滞留製剤
WO2008087882A1 (ja) * 2007-01-15 2008-07-24 Kissei Pharmaceutical Co., Ltd. 胃内滞留型レボドパ徐放性製剤
EP2262484B1 (de) * 2008-03-11 2013-01-23 Depomed, Inc. Gastroretentive darreichungsformen mit verzögerter freisetzung mit komibinationen aus einem nichtopioiden analgetikum und einem opioiden analgetikum
EP2163240A1 (de) * 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova Verfahren zur Herstellung von bioadhesiven Kompaktmatrizen
JP5594484B2 (ja) 2009-07-06 2014-09-24 杏林製薬株式会社 中空構造を有する錠剤
MX356789B (es) * 2013-01-16 2018-06-12 Invekra S A P I De C V Composición de difenidol de liberación prolongada.
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2951792A (en) * 1959-11-18 1960-09-06 Smith Kline French Lab Sustained release pharmaceutical tablets
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4424235A (en) * 1981-09-14 1984-01-03 Hoffmann-La Roche Inc. Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
JPH06143108A (ja) * 1992-10-30 1994-05-24 Nec Corp 溝加工方法及び溝加工装置

Also Published As

Publication number Publication date
DE69017915T2 (de) 1995-07-27
US5368861A (en) 1994-11-29
EP0497977A4 (en) 1992-09-16
WO1991006281A1 (en) 1991-05-16
EP0497977B1 (de) 1995-03-15
ATE119766T1 (de) 1995-04-15
EP0497977A1 (de) 1992-08-12

Similar Documents

Publication Publication Date Title
DE69017915T2 (de) Zubereitung für den magen.
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
LU91037I2 (fr) Somatulina autogel
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
NO920740L (no) Doseringsform for oral administrering av hypoglykemisk glipizid
GR3007202T3 (de)
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
PT85829A (en) Therapeutic agents
FR2604090B1 (fr) Forme de dosage pharmaceutique solide comprenant au moins une unite a liberation controlee
MX9203543A (es) Medicamento.
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
IS3644A7 (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
DK62187A (da) Farmaceutisk praeparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf
FR2628971B1 (fr) Forme d'administration solide, a desagregation rapide, du diclofenac
MC2025A1 (fr) Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
OA08957A (fr) Dérivés d'alcadiènes, leurs préparations, les médicaments les contenant et produits intermédiaires
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
MY100780A (en) Azumolene dosage form.
DK166343C (da) Forbedret piroxicamholdigt laegemiddel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee